AU2001252945A1 - Compositions and methods for therapy and diagnosis of colon cancer - Google Patents

Compositions and methods for therapy and diagnosis of colon cancer

Info

Publication number
AU2001252945A1
AU2001252945A1 AU2001252945A AU5294501A AU2001252945A1 AU 2001252945 A1 AU2001252945 A1 AU 2001252945A1 AU 2001252945 A AU2001252945 A AU 2001252945A AU 5294501 A AU5294501 A AU 5294501A AU 2001252945 A1 AU2001252945 A1 AU 2001252945A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252945A
Inventor
Gordon E. King
Madeleine Joy Meagher
Jiangchun Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001252945A1 publication Critical patent/AU2001252945A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001252945A 2000-03-24 2001-03-22 Compositions and methods for therapy and diagnosis of colon cancer Abandoned AU2001252945A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US19159700P 2000-03-24 2000-03-24
US60191597 2000-03-24
US20202400P 2000-05-04 2000-05-04
US60202024 2000-05-04
US20218900P 2000-05-05 2000-05-05
US60202189 2000-05-05
PCT/US2001/009246 WO2001073027A2 (en) 2000-03-24 2001-03-22 Compositions and methods for therapy and diagnosis of colon cancer

Publications (1)

Publication Number Publication Date
AU2001252945A1 true AU2001252945A1 (en) 2001-10-08

Family

ID=27392914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252945A Abandoned AU2001252945A1 (en) 2000-03-24 2001-03-22 Compositions and methods for therapy and diagnosis of colon cancer

Country Status (3)

Country Link
US (1) US20010055596A1 (en)
AU (1) AU2001252945A1 (en)
WO (1) WO2001073027A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002503468A (en) 1998-02-17 2002-02-05 アンスティテュー・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル・（イー・エヌ・エス・ウ・エール・エム） Member of the D52 gene family
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
AU2001261424A1 (en) * 2000-05-11 2001-11-20 Incyte Genomics, Inc. Lipid metabolism enzymes
JP2004512023A (en) * 2000-06-09 2004-04-22 コリクサ　コーポレイション Compositions and methods for treatment and diagnosis of colon cancer
US20030069180A1 (en) * 2000-06-09 2003-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP1579220B1 (en) 2002-12-20 2007-08-15 Roche Diagnostics GmbH Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
WO2005014818A1 (en) 2003-08-08 2005-02-17 Perseus Proteomics Inc. Gene overexpressed in cancer
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2005118802A2 (en) 2004-06-03 2005-12-15 The Regents Of The University Of California Targeting pseudotyped retroviral vectors
ES2371083T3 (en) 2004-12-21 2011-12-27 Medimmune Limited ANTIBODIES DIRECTED AGAINST ANGIOPOYETINA-2 AND USES OF THE SAME.
US8535914B2 (en) * 2005-01-21 2013-09-17 Canon Kabushiki Kaisha Probe, probe set and information acquisition method using the same
CA2662915A1 (en) * 2006-09-08 2008-03-13 Corixa Corporation Methods, compositions, and kits for the detection and monitoring of colon cancer
EP2215261B1 (en) * 2007-10-23 2018-02-21 Clinical Genomics Pty Ltd A method of diagnosing neoplasms
US20130323756A1 (en) * 2010-07-07 2013-12-05 Aethlon Medical, Inc. Methods and compositions for quantifying exosomes
JP2014509189A (en) 2011-01-25 2014-04-17 アルマック ダイアグノスティックス リミテッド Colon cancer gene expression signature and methods of use
ITUB20150652A1 (en) 2015-05-21 2016-11-21 Univ Bologna Alma Mater Studiorum NEW DIAGNOSTIC METHOD AND KIT
WO2018208856A1 (en) 2017-05-08 2018-11-15 Gritstone Oncology, Inc. Alphavirus neoantigen vectors
AU2019205330A1 (en) 2018-01-04 2020-08-27 Iconic Therapeutics Llc Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
WO2020243719A1 (en) 2019-05-30 2020-12-03 Gritstone Oncology, Inc. Modified adenoviruses
IL300026A (en) 2020-08-06 2023-03-01 Gritstone Bio Inc Multiepitope vaccine cassettes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8800604A1 (en) * 1985-04-22 1987-11-16 Hybritech Inc A tumor associated antigen.
ES2090331T3 (en) * 1990-04-12 1996-10-16 Akzo Nobel Nv CTAA 28A32, ANTIGEN RECOGNIZED BY MCA 28A32.
AUPO957397A0 (en) * 1997-10-01 1997-10-30 St. Vincent's Institute Of Medical Research Transporter protein
AU5691699A (en) * 1998-08-31 2000-03-21 Bayer Corporation Human genes differentially expressed in colorectal cancer

Also Published As

Publication number Publication date
WO2001073027A2 (en) 2001-10-04
WO2001073027A3 (en) 2002-06-27
US20010055596A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer